CXCR2 and neoplasm: To increase the infiltration and homing capacity, CARs can be used that express chemokine receptors (CCRs) compatible with chemokine CC (CCL) ligands of tumor cells, for example, CXCR2-expressing NK cells show significant migration to tumors expressing CXCR2 ligands [108, 109].